![First-Line Maintenance Strategies for Ovarian Cancer with Bevacizumab and PARP Inhibitors – EIOC](https://oncodaily.com/pub/uploads/2024/08/DHA-e1722882662491.jpg)
Photo taken from EIOC/X
Aug 6, 2024, 01:14
First-Line Maintenance Strategies for Ovarian Cancer with Bevacizumab and PARP Inhibitors – EIOC
Excellence in Oncology Care (EIOC) shared on X:
“Save the Date!
Join our virtual journal club on 2nd Sep 2024, 19:00-20:00 (UAE Time) on First-Line Maintenance Strategies for Ovarian Cancer with Bevacizumab and PARP Inhibitors. CME (Continuing Medical Education) applied with DHA (Dubai Health Authority).
Register Now!”
Source: EIOC/X
Aug 5, 2024, 18:12